Cargando…
MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3
Objectives: Ovarian cancer is the most lethal gynecologic malignancy, and targeted therapy for different pathological types and molecular phenotypes is urgent to be studied. Studies have shown that MicroRNA-592 (miR-592) plays an important negative regulatory role in the occurrence of gastrointestin...
Autores principales: | Jin, Qiong, Zhang, Ning, Zhan, Yang, Xu, Xiaohong, Han, Chao, Zhao, Hui, Hu, Xiaodi, Tang, Hongbo, Wu, Yumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021105/ https://www.ncbi.nlm.nih.gov/pubmed/36916303 http://dx.doi.org/10.1177/15330338231157156 |
Ejemplares similares
-
Predictive Value of FNA-Tg and TgAb in Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma
por: Wu, Xiaoli, et al.
Publicado: (2022) -
Isatuximab in the Treatment of Multiple Myeloma: A Review and
Comparison With Daratumumab
por: Shen, Fei, et al.
Publicado: (2022) -
Treatment with b-AP15 to Inhibit UCHL5 and USP14 Deubiquitinating Activity and Enhance p27 and Cyclin E1 for Tumors with p53 Deficiency
por: Jiang, Zong-Yuan, et al.
Publicado: (2022) -
Sequential Administrations of a Vascular-Disrupting Agent,
High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid
Compound for Eradicating Solid Malignancies
por: Li, Yue, et al.
Publicado: (2022) -
RhoA G17E/Vav1 Signaling Induces Cancer Invasion via Matrix Metalloproteinase-9 in Gastric Cancer
por: Nakamura, Satoshi, et al.
Publicado: (2023)